Mixtard 30 to be discontinued

NovoNordisk is discontinuing all presentations of Mixtard 30 at the end of the year, for commercial reasons. The Penfill cartridges, prefilled InnoLet injector and 10ml vials of the biphasic insulin - a mixture of 30% soluble and 70% isophane insulin - will all be withdrawn on 31 December.

Prescribers should ensure that patients are changed to an alternative insulin preparation before this date. When choosing an alternative insulin, prescribers should take into consideration the equivalent dose and type of insulin, suitability of the device and cost. The decision should be made on a case by case basis.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Statin prescribing 'commonly breaching NICE guidance'

Statin prescribing 'commonly breaching NICE guidance'

Prescribing of suboptimal statin regimens is 'extremely...

New contraindication for co-cyprindiol

New contraindication for co-cyprindiol

Cyproterone-containing medicines are now contraindicated...

GPs demand clarity on flu vaccination plans for 2020/21

GPs demand clarity on flu vaccination plans for 2020/21

GPs say they are struggling to plan flu vaccine orders...